Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Arcus Biosciences (RCUS) Other Gross PP&E Adjustments (2017 - 2025)

Arcus Biosciences has reported Other Gross PP&E Adjustments over the past 9 years, most recently at $64.0 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $64.0 million for Q4 2025, up 4.92% from a year ago — trailing twelve months through Dec 2025 was $64.0 million (up 4.92% YoY), and the annual figure for FY2025 was $64.0 million, up 4.92%.
  • Other Gross PP&E Adjustments for Q4 2025 was $64.0 million at Arcus Biosciences, up from $61.0 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for RCUS hit a ceiling of $64.0 million in Q4 2025 and a floor of -$104.3 million in Q2 2022.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$36.1 million (2021), compared with a mean of -$21.1 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 8333.87% in 2021 and later surged 164.65% in 2022.
  • Arcus Biosciences' Other Gross PP&E Adjustments stood at -$65.0 million in 2021, then surged by 164.65% to $42.0 million in 2022, then skyrocketed by 45.24% to $61.0 million in 2023, then changed by 0.0% to $61.0 million in 2024, then grew by 4.92% to $64.0 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $64.0 million (Q4 2025), $61.0 million (Q4 2024), and $61.0 million (Q4 2023) per Business Quant data.